Look up one drug

Ontario coverage, price, criteria word for word, Health Canada status and shortages for one product

Patient plan: look up a medication list

WARFARIN

14 general benefit · 9 not a benefit

Other products in the same Health Canada class (B01A) — coverage varies; not interchangeable

  • Apixaban (Eliquis): general benefit
  • Dabigatran etexilate (Pradaxa): general benefit, Not a benefit
  • Edoxaban (Lixiana): general benefit
  • Enoxaparin (Noromby): general benefit
  • Rivaroxaban (Xarelto): general benefit
  • Dalteparin (Fragmin): limited Use 186, 187, 188, 189

5 more in the class list below

Apo-Warfarin · DIN 02242924 · 1mg · tablet

General benefitMarketed · checked 2026-09-02
StatusGeneral benefit
Write on scriptno code needed
Patient paysPatient pays: program not supplied; amount cannot be determined.
Private plan unknown: ask. If yes, check its coverage and payer coordination; if no, see the public routes below.
1 brand, same coverage
Apo-Warfarin · DIN 02242924 Manufacturer: Apotex Inc.; listing date 2001-06-07 Health Canada: Marketed since 2000-10-16 · brand APO-WARFARIN · ATC B01AA03 WARFARIN · form Tablet · route Oral · ingredients WARFARIN SODIUM 1 MG · company Apotex inc · schedule Prescription
Check this DIN again · Health Canada product record

Apo-Warfarin: Formulary list price $0.0796/unit (unit not stated in source; not the patient's cost)

Ministry pays: $0.0796 per source unit.

Source explanation: The formulary price is what ODB pays; the cash price at the counter is set by the pharmacy.

Formulary data: Ontario extract of Aug 26, 2026 · Health Canada DPD extract of Sep 2, 2026 (Open Government Licence – Canada) · https://health-products.canada.ca/dpd-bdpp/info?lang=eng&code=66762 · Verify on the e-Formulary ↗ (DIN 02242924)

Source record
DIN 02242924: Apo-Warfarin Raw flags: sec3=Y Item: 201200026; group id 263; item number 0523; lccId None; manufacturer id APX Source form: Tab; strength: 1mg Recorded listing: General benefit Source prices (unrounded): $0.0796; ministry $0.0796 Source: ODB odb-formulary-ed43-extract-2026-08-26.xml extract_date=2026-08-26 DIN=02242924 Health Canada DPD extract of Sep 2, 2026 (Open Government Licence – Canada) · https://health-products.canada.ca/dpd-bdpp/info?lang=eng&code=66762
Interchangeable products
Coumadin · DIN 01918311 · not recorded Taro-Warfarin · DIN 02242680 · $0.0796
Shortage status: resolved shortage (ended 2026-07-30); reports as of 2026-09-13T08:10:21.292534+00:00 (Health Product Shortages Canada) Source: https://healthproductshortages.ca/search?term=02242924
Shortage record checked 2026-09-13T08:10:21.292534+00:00

Taro-Warfarin · DIN 02242680 · 1mg · tablet

General benefitMarketed · checked 2026-09-02
StatusGeneral benefit
Write on scriptno code needed
Patient paysPatient pays: program not supplied; amount cannot be determined.
Private plan unknown: ask. If yes, check its coverage and payer coordination; if no, see the public routes below.
1 brand, same coverage
Taro-Warfarin · DIN 02242680 Manufacturer: Taro Pharmaceuticals Inc.; listing date 2001-06-07 Health Canada: Marketed since 2000-08-09 · brand TARO-WARFARIN · ATC B01AA03 WARFARIN · form Tablet · route Oral · ingredients WARFARIN SODIUM 1 MG · company Taro pharmaceuticals inc · schedule Prescription
Check this DIN again · Health Canada product record

Taro-Warfarin: Formulary list price $0.0796/unit (unit not stated in source; not the patient's cost)

Ministry pays: $0.0796 per source unit.

Source explanation: The formulary price is what ODB pays; the cash price at the counter is set by the pharmacy.

Formulary data: Ontario extract of Aug 26, 2026 · Health Canada DPD extract of Sep 2, 2026 (Open Government Licence – Canada) · https://health-products.canada.ca/dpd-bdpp/info?lang=eng&code=66470 · Verify on the e-Formulary ↗ (DIN 02242680)

Source record
DIN 02242680: Taro-Warfarin Raw flags: sec3=Y Item: 201200026; group id 263; item number 0523; lccId None; manufacturer id TAR Source form: Tab; strength: 1mg Recorded listing: General benefit Source prices (unrounded): $0.0796; ministry $0.0796 Source: ODB odb-formulary-ed43-extract-2026-08-26.xml extract_date=2026-08-26 DIN=02242680 Health Canada DPD extract of Sep 2, 2026 (Open Government Licence – Canada) · https://health-products.canada.ca/dpd-bdpp/info?lang=eng&code=66470
Interchangeable products
Apo-Warfarin · DIN 02242924 · $0.0796 Coumadin · DIN 01918311 · not recorded
Shortage status: resolved shortage (ended 2026-06-30); reports as of 2026-09-13T08:10:21.292534+00:00 (Health Product Shortages Canada) Source: https://healthproductshortages.ca/search?term=02242680
Shortage record checked 2026-09-13T08:10:21.292534+00:00

Apo-Warfarin · DIN 02242925 · 2mg · tablet

General benefitMarketed · checked 2026-09-02
StatusGeneral benefit
Write on scriptno code needed
Patient paysPatient pays: program not supplied; amount cannot be determined.
Private plan unknown: ask. If yes, check its coverage and payer coordination; if no, see the public routes below.
1 brand, same coverage
Apo-Warfarin · DIN 02242925 Manufacturer: Apotex Inc.; listing date 2001-06-07 Health Canada: Marketed since 2000-10-16 · brand APO-WARFARIN · ATC B01AA03 WARFARIN · form Tablet · route Oral · ingredients WARFARIN SODIUM 2 MG · company Apotex inc · schedule Prescription
Check this DIN again · Health Canada product record

Apo-Warfarin: Formulary list price $0.0841/unit (unit not stated in source; not the patient's cost)

Ministry pays: $0.0841 per source unit.

Source explanation: The formulary price is what ODB pays; the cash price at the counter is set by the pharmacy.

Formulary data: Ontario extract of Aug 26, 2026 · Health Canada DPD extract of Sep 2, 2026 (Open Government Licence – Canada) · https://health-products.canada.ca/dpd-bdpp/info?lang=eng&code=66763 · Verify on the e-Formulary ↗ (DIN 02242925)

Source record
DIN 02242925: Apo-Warfarin Raw flags: sec3=Y Item: 201200027; group id 263; item number 0524; lccId None; manufacturer id APX Source form: Tab; strength: 2mg Recorded listing: General benefit Source prices (unrounded): $0.0841; ministry $0.0841 Source: ODB odb-formulary-ed43-extract-2026-08-26.xml extract_date=2026-08-26 DIN=02242925 Health Canada DPD extract of Sep 2, 2026 (Open Government Licence – Canada) · https://health-products.canada.ca/dpd-bdpp/info?lang=eng&code=66763
Interchangeable products
Coumadin · DIN 01918338 · not recorded Taro-Warfarin · DIN 02242681 · $0.0841
Shortage status: resolved shortage (ended 2025-09-25); reports as of 2026-09-13T08:10:21.292534+00:00 (Health Product Shortages Canada) Source: https://healthproductshortages.ca/search?term=02242925
Shortage record checked 2026-09-13T08:10:21.292534+00:00

Taro-Warfarin · DIN 02242681 · 2mg · tablet

General benefitMarketed · checked 2026-09-02
StatusGeneral benefit
Write on scriptno code needed
Patient paysPatient pays: program not supplied; amount cannot be determined.
Private plan unknown: ask. If yes, check its coverage and payer coordination; if no, see the public routes below.
1 brand, same coverage
Taro-Warfarin · DIN 02242681 Manufacturer: Taro Pharmaceuticals Inc.; listing date 2001-06-07 Health Canada: Marketed since 2000-08-09 · brand TARO-WARFARIN · ATC B01AA03 WARFARIN · form Tablet · route Oral · ingredients WARFARIN SODIUM 2 MG · company Taro pharmaceuticals inc · schedule Prescription
Check this DIN again · Health Canada product record

Taro-Warfarin: Formulary list price $0.0841/unit (unit not stated in source; not the patient's cost)

Ministry pays: $0.0841 per source unit.

Source explanation: The formulary price is what ODB pays; the cash price at the counter is set by the pharmacy.

Formulary data: Ontario extract of Aug 26, 2026 · Health Canada DPD extract of Sep 2, 2026 (Open Government Licence – Canada) · https://health-products.canada.ca/dpd-bdpp/info?lang=eng&code=66471 · Verify on the e-Formulary ↗ (DIN 02242681)

Source record
DIN 02242681: Taro-Warfarin Raw flags: sec3=Y Item: 201200027; group id 263; item number 0524; lccId None; manufacturer id TAR Source form: Tab; strength: 2mg Recorded listing: General benefit Source prices (unrounded): $0.0841; ministry $0.0841 Source: ODB odb-formulary-ed43-extract-2026-08-26.xml extract_date=2026-08-26 DIN=02242681 Health Canada DPD extract of Sep 2, 2026 (Open Government Licence – Canada) · https://health-products.canada.ca/dpd-bdpp/info?lang=eng&code=66471
Interchangeable products
Apo-Warfarin · DIN 02242925 · $0.0841 Coumadin · DIN 01918338 · not recorded
Shortage status: resolved shortage (ended 2026-05-21); reports as of 2026-09-13T08:10:21.292534+00:00 (Health Product Shortages Canada) Source: https://healthproductshortages.ca/search?term=02242681
Shortage record checked 2026-09-13T08:10:21.292534+00:00

Apo-Warfarin · DIN 02242926 · 2.5mg · tablet

General benefitMarketed · checked 2026-09-02
StatusGeneral benefit
Write on scriptno code needed
Patient paysPatient pays: program not supplied; amount cannot be determined.
Private plan unknown: ask. If yes, check its coverage and payer coordination; if no, see the public routes below.
1 brand, same coverage
Apo-Warfarin · DIN 02242926 Manufacturer: Apotex Inc.; listing date 2001-06-07 Health Canada: Marketed since 2000-10-16 · brand APO-WARFARIN · ATC B01AA03 WARFARIN · form Tablet · route Oral · ingredients WARFARIN SODIUM 2.5 MG · company Apotex inc · schedule Prescription
Check this DIN again · Health Canada product record

Apo-Warfarin: Formulary list price $0.0674/unit (unit not stated in source; not the patient's cost)

Ministry pays: $0.0674 per source unit.

Source explanation: The formulary price is what ODB pays; the cash price at the counter is set by the pharmacy.

Formulary data: Ontario extract of Aug 26, 2026 · Health Canada DPD extract of Sep 2, 2026 (Open Government Licence – Canada) · https://health-products.canada.ca/dpd-bdpp/info?lang=eng&code=66764 · Verify on the e-Formulary ↗ (DIN 02242926)

Source record
DIN 02242926: Apo-Warfarin Raw flags: sec3=Y Item: 201200010; group id 263; item number 0525; lccId None; manufacturer id APX Source form: Tab; strength: 2.5mg Recorded listing: General benefit Source prices (unrounded): $0.0674; ministry $0.0674 Source: ODB odb-formulary-ed43-extract-2026-08-26.xml extract_date=2026-08-26 DIN=02242926 Health Canada DPD extract of Sep 2, 2026 (Open Government Licence – Canada) · https://health-products.canada.ca/dpd-bdpp/info?lang=eng&code=66764
Interchangeable products
Coumadin · DIN 01918346 · not recorded Taro-Warfarin · DIN 02242682 · $0.0674
Shortage status: active shortage (reported 2024-05-28, last updated 2024-10-24); reports as of 2026-09-13T08:10:21.292534+00:00 (Health Product Shortages Canada) Source: https://healthproductshortages.ca/search?term=02242926
Shortage record checked 2026-09-13T08:10:21.292534+00:00

Taro-Warfarin · DIN 02242682 · 2.5mg · tablet

General benefitMarketed · checked 2026-09-02
StatusGeneral benefit
Write on scriptno code needed
Patient paysPatient pays: program not supplied; amount cannot be determined.
Private plan unknown: ask. If yes, check its coverage and payer coordination; if no, see the public routes below.
1 brand, same coverage
Taro-Warfarin · DIN 02242682 Manufacturer: Taro Pharmaceuticals Inc.; listing date 2001-06-07 Health Canada: Marketed since 2000-08-09 · brand TARO-WARFARIN · ATC B01AA03 WARFARIN · form Tablet · route Oral · ingredients WARFARIN SODIUM 2.5 MG · company Taro pharmaceuticals inc · schedule Prescription
Check this DIN again · Health Canada product record

Taro-Warfarin: Formulary list price $0.0674/unit (unit not stated in source; not the patient's cost)

Ministry pays: $0.0674 per source unit.

Source explanation: The formulary price is what ODB pays; the cash price at the counter is set by the pharmacy.

Formulary data: Ontario extract of Aug 26, 2026 · Health Canada DPD extract of Sep 2, 2026 (Open Government Licence – Canada) · https://health-products.canada.ca/dpd-bdpp/info?lang=eng&code=66472 · Verify on the e-Formulary ↗ (DIN 02242682)

Source record
DIN 02242682: Taro-Warfarin Raw flags: sec3=Y Item: 201200010; group id 263; item number 0525; lccId None; manufacturer id TAR Source form: Tab; strength: 2.5mg Recorded listing: General benefit Source prices (unrounded): $0.0674; ministry $0.0674 Source: ODB odb-formulary-ed43-extract-2026-08-26.xml extract_date=2026-08-26 DIN=02242682 Health Canada DPD extract of Sep 2, 2026 (Open Government Licence – Canada) · https://health-products.canada.ca/dpd-bdpp/info?lang=eng&code=66472
Interchangeable products
Apo-Warfarin · DIN 02242926 · $0.0674 Coumadin · DIN 01918346 · not recorded
Shortage status: resolved shortage (ended 2026-08-04); reports as of 2026-09-13T08:10:21.292534+00:00 (Health Product Shortages Canada) Source: https://healthproductshortages.ca/search?term=02242682
Shortage record checked 2026-09-13T08:10:21.292534+00:00

Apo-Warfarin · DIN 02245618 · 3mg · tablet

General benefitMarketed · checked 2026-09-02
StatusGeneral benefit
Write on scriptno code needed
Patient paysPatient pays: program not supplied; amount cannot be determined.
Private plan unknown: ask. If yes, check its coverage and payer coordination; if no, see the public routes below.
1 brand, same coverage
Apo-Warfarin · DIN 02245618 Manufacturer: Apotex Inc.; listing date 2003-01-30 Health Canada: Marketed since 2002-04-23 · brand APO-WARFARIN · ATC B01AA03 WARFARIN · form Tablet · route Oral · ingredients WARFARIN SODIUM 3 MG · company Apotex inc · schedule Prescription
Check this DIN again · Health Canada product record

Apo-Warfarin: Formulary list price $0.1043/unit (unit not stated in source; not the patient's cost)

Ministry pays: $0.1043 per source unit.

Source explanation: The formulary price is what ODB pays; the cash price at the counter is set by the pharmacy.

Formulary data: Ontario extract of Aug 26, 2026 · Health Canada DPD extract of Sep 2, 2026 (Open Government Licence – Canada) · https://health-products.canada.ca/dpd-bdpp/info?lang=eng&code=69718 · Verify on the e-Formulary ↗ (DIN 02245618)

Source record
DIN 02245618: Apo-Warfarin Raw flags: sec3=Y Item: 201200062; group id 263; item number 0526; lccId None; manufacturer id APX Source form: Tab; strength: 3mg Recorded listing: General benefit Source prices (unrounded): $0.1043; ministry $0.1043 Source: ODB odb-formulary-ed43-extract-2026-08-26.xml extract_date=2026-08-26 DIN=02245618 Health Canada DPD extract of Sep 2, 2026 (Open Government Licence – Canada) · https://health-products.canada.ca/dpd-bdpp/info?lang=eng&code=69718
Interchangeable products
Coumadin · DIN 02240205 · not recorded Taro-Warfarin · DIN 02242683 · $0.1043
Shortage status: no shortage or discontinuation reported (checked 2026-09-13T08:10:21.292534+00:00); reports as of 2026-09-13T08:10:21.292534+00:00 (Health Product Shortages Canada) Source: https://healthproductshortages.ca/search?term=02245618
Shortage record checked 2026-09-13T08:10:21.292534+00:00

Taro-Warfarin · DIN 02242683 · 3mg · tablet

General benefitMarketed · checked 2026-09-02
StatusGeneral benefit
Write on scriptno code needed
Patient paysPatient pays: program not supplied; amount cannot be determined.
Private plan unknown: ask. If yes, check its coverage and payer coordination; if no, see the public routes below.
1 brand, same coverage
Taro-Warfarin · DIN 02242683 Manufacturer: Taro Pharmaceuticals Inc.; listing date 2002-04-04 Health Canada: Marketed since 2000-08-09 · brand TARO-WARFARIN · ATC B01AA03 WARFARIN · form Tablet · route Oral · ingredients WARFARIN SODIUM 3 MG · company Taro pharmaceuticals inc · schedule Prescription
Check this DIN again · Health Canada product record

Taro-Warfarin: Formulary list price $0.1043/unit (unit not stated in source; not the patient's cost)

Ministry pays: $0.1043 per source unit.

Source explanation: The formulary price is what ODB pays; the cash price at the counter is set by the pharmacy.

Formulary data: Ontario extract of Aug 26, 2026 · Health Canada DPD extract of Sep 2, 2026 (Open Government Licence – Canada) · https://health-products.canada.ca/dpd-bdpp/info?lang=eng&code=66473 · Verify on the e-Formulary ↗ (DIN 02242683)

Source record
DIN 02242683: Taro-Warfarin Raw flags: sec3=Y Item: 201200062; group id 263; item number 0526; lccId None; manufacturer id TAR Source form: Tab; strength: 3mg Recorded listing: General benefit Source prices (unrounded): $0.1043; ministry $0.1043 Source: ODB odb-formulary-ed43-extract-2026-08-26.xml extract_date=2026-08-26 DIN=02242683 Health Canada DPD extract of Sep 2, 2026 (Open Government Licence – Canada) · https://health-products.canada.ca/dpd-bdpp/info?lang=eng&code=66473
Interchangeable products
Apo-Warfarin · DIN 02245618 · $0.1043 Coumadin · DIN 02240205 · not recorded
Shortage status: discontinued (2021-11-25, reported by TARO PHARMACEUTICALS INC); reports as of 2026-09-13T08:10:21.292534+00:00 (Health Product Shortages Canada) Source: https://healthproductshortages.ca/search?term=02242683
Shortage record checked 2026-09-13T08:10:21.292534+00:00

Apo-Warfarin · DIN 02242927 · 4mg · tablet

General benefitMarketed · checked 2026-09-02
StatusGeneral benefit
Write on scriptno code needed
Patient paysPatient pays: program not supplied; amount cannot be determined.
Private plan unknown: ask. If yes, check its coverage and payer coordination; if no, see the public routes below.
1 brand, same coverage
Apo-Warfarin · DIN 02242927 Manufacturer: Apotex Inc.; listing date 2001-06-07 Health Canada: Marketed since 2000-10-16 · brand APO-WARFARIN · ATC B01AA03 WARFARIN · form Tablet · route Oral · ingredients WARFARIN SODIUM 4 MG · company Apotex inc · schedule Prescription
Check this DIN again · Health Canada product record

Apo-Warfarin: Formulary list price $0.1043/unit (unit not stated in source; not the patient's cost)

Ministry pays: $0.1043 per source unit.

Source explanation: The formulary price is what ODB pays; the cash price at the counter is set by the pharmacy.

Formulary data: Ontario extract of Aug 26, 2026 · Health Canada DPD extract of Sep 2, 2026 (Open Government Licence – Canada) · https://health-products.canada.ca/dpd-bdpp/info?lang=eng&code=66765 · Verify on the e-Formulary ↗ (DIN 02242927)

Source record
DIN 02242927: Apo-Warfarin Raw flags: sec3=Y Item: 201200028; group id 263; item number 0527; lccId None; manufacturer id APX Source form: Tab; strength: 4mg Recorded listing: General benefit Source prices (unrounded): $0.1043; ministry $0.1043 Source: ODB odb-formulary-ed43-extract-2026-08-26.xml extract_date=2026-08-26 DIN=02242927 Health Canada DPD extract of Sep 2, 2026 (Open Government Licence – Canada) · https://health-products.canada.ca/dpd-bdpp/info?lang=eng&code=66765
Interchangeable products
Coumadin · DIN 02007959 · not recorded Taro-Warfarin · DIN 02242684 · $0.1043
Shortage status: resolved shortage (ended 2018-06-26); reports as of 2026-09-13T08:10:21.292534+00:00 (Health Product Shortages Canada) Source: https://healthproductshortages.ca/search?term=02242927
Shortage record checked 2026-09-13T08:10:21.292534+00:00

Taro-Warfarin · DIN 02242684 · 4mg · tablet

General benefitMarketed · checked 2026-09-02
StatusGeneral benefit
Write on scriptno code needed
Patient paysPatient pays: program not supplied; amount cannot be determined.
Private plan unknown: ask. If yes, check its coverage and payer coordination; if no, see the public routes below.
1 brand, same coverage
Taro-Warfarin · DIN 02242684 Manufacturer: Taro Pharmaceuticals Inc.; listing date 2001-06-07 Health Canada: Marketed since 2000-08-09 · brand TARO-WARFARIN · ATC B01AA03 WARFARIN · form Tablet · route Oral · ingredients WARFARIN SODIUM 4 MG · company Taro pharmaceuticals inc · schedule Prescription
Check this DIN again · Health Canada product record

Taro-Warfarin: Formulary list price $0.1043/unit (unit not stated in source; not the patient's cost)

Ministry pays: $0.1043 per source unit.

Source explanation: The formulary price is what ODB pays; the cash price at the counter is set by the pharmacy.

Formulary data: Ontario extract of Aug 26, 2026 · Health Canada DPD extract of Sep 2, 2026 (Open Government Licence – Canada) · https://health-products.canada.ca/dpd-bdpp/info?lang=eng&code=66474 · Verify on the e-Formulary ↗ (DIN 02242684)

Source record
DIN 02242684: Taro-Warfarin Raw flags: sec3=Y Item: 201200028; group id 263; item number 0527; lccId None; manufacturer id TAR Source form: Tab; strength: 4mg Recorded listing: General benefit Source prices (unrounded): $0.1043; ministry $0.1043 Source: ODB odb-formulary-ed43-extract-2026-08-26.xml extract_date=2026-08-26 DIN=02242684 Health Canada DPD extract of Sep 2, 2026 (Open Government Licence – Canada) · https://health-products.canada.ca/dpd-bdpp/info?lang=eng&code=66474
Interchangeable products
Apo-Warfarin · DIN 02242927 · $0.1043 Coumadin · DIN 02007959 · not recorded
Shortage status: resolved shortage (ended 2025-12-10); reports as of 2026-09-13T08:10:21.292534+00:00 (Health Product Shortages Canada) Source: https://healthproductshortages.ca/search?term=02242684
Shortage record checked 2026-09-13T08:10:21.292534+00:00

Apo-Warfarin · DIN 02242928 · 5mg · tablet

General benefitMarketed · checked 2026-09-02
StatusGeneral benefit
Write on scriptno code needed
Patient paysPatient pays: program not supplied; amount cannot be determined.
Private plan unknown: ask. If yes, check its coverage and payer coordination; if no, see the public routes below.
1 brand, same coverage
Apo-Warfarin · DIN 02242928 Manufacturer: Apotex Inc.; listing date 2001-06-07 Health Canada: Marketed since 2000-10-16 · brand APO-WARFARIN · ATC B01AA03 WARFARIN · form Tablet · route Oral · ingredients WARFARIN SODIUM 5 MG · company Apotex inc · schedule Prescription
Check this DIN again · Health Canada product record

Apo-Warfarin: Formulary list price $0.0675/unit (unit not stated in source; not the patient's cost)

Ministry pays: $0.0675 per source unit.

Source explanation: The formulary price is what ODB pays; the cash price at the counter is set by the pharmacy.

Formulary data: Ontario extract of Aug 26, 2026 · Health Canada DPD extract of Sep 2, 2026 (Open Government Licence – Canada) · https://health-products.canada.ca/dpd-bdpp/info?lang=eng&code=66766 · Verify on the e-Formulary ↗ (DIN 02242928)

Source record
DIN 02242928: Apo-Warfarin Raw flags: sec3=Y Item: 201200035; group id 263; item number 0528; lccId None; manufacturer id APX Source form: Tab; strength: 5mg Recorded listing: General benefit Source prices (unrounded): $0.0675; ministry $0.0675 Source: ODB odb-formulary-ed43-extract-2026-08-26.xml extract_date=2026-08-26 DIN=02242928 Health Canada DPD extract of Sep 2, 2026 (Open Government Licence – Canada) · https://health-products.canada.ca/dpd-bdpp/info?lang=eng&code=66766
Interchangeable products
Coumadin · DIN 01918354 · not recorded Taro-Warfarin · DIN 02242685 · $0.0675
Shortage status: resolved shortage (ended 2020-12-24); reports as of 2026-09-13T08:10:21.292534+00:00 (Health Product Shortages Canada) Source: https://healthproductshortages.ca/search?term=02242928
Shortage record checked 2026-09-13T08:10:21.292534+00:00

Taro-Warfarin · DIN 02242685 · 5mg · tablet

General benefitMarketed · checked 2026-09-02
StatusGeneral benefit
Write on scriptno code needed
Patient paysPatient pays: program not supplied; amount cannot be determined.
Private plan unknown: ask. If yes, check its coverage and payer coordination; if no, see the public routes below.
1 brand, same coverage
Taro-Warfarin · DIN 02242685 Manufacturer: Taro Pharmaceuticals Inc.; listing date 2001-06-07 Health Canada: Marketed since 2000-08-09 · brand TARO-WARFARIN · ATC B01AA03 WARFARIN · form Tablet · route Oral · ingredients WARFARIN SODIUM 5 MG · company Taro pharmaceuticals inc · schedule Prescription
Check this DIN again · Health Canada product record

Taro-Warfarin: Formulary list price $0.0675/unit (unit not stated in source; not the patient's cost)

Ministry pays: $0.0675 per source unit.

Source explanation: The formulary price is what ODB pays; the cash price at the counter is set by the pharmacy.

Formulary data: Ontario extract of Aug 26, 2026 · Health Canada DPD extract of Sep 2, 2026 (Open Government Licence – Canada) · https://health-products.canada.ca/dpd-bdpp/info?lang=eng&code=66475 · Verify on the e-Formulary ↗ (DIN 02242685)

Source record
DIN 02242685: Taro-Warfarin Raw flags: sec3=Y Item: 201200035; group id 263; item number 0528; lccId None; manufacturer id TAR Source form: Tab; strength: 5mg Recorded listing: General benefit Source prices (unrounded): $0.0675; ministry $0.0675 Source: ODB odb-formulary-ed43-extract-2026-08-26.xml extract_date=2026-08-26 DIN=02242685 Health Canada DPD extract of Sep 2, 2026 (Open Government Licence – Canada) · https://health-products.canada.ca/dpd-bdpp/info?lang=eng&code=66475
Interchangeable products
Apo-Warfarin · DIN 02242928 · $0.0675 Coumadin · DIN 01918354 · not recorded
Shortage status: discontinued (2023-09-22, reported by TARO PHARMACEUTICALS INC); reports as of 2026-09-13T08:10:21.292534+00:00 (Health Product Shortages Canada) Source: https://healthproductshortages.ca/search?term=02242685
Shortage record checked 2026-09-13T08:10:21.292534+00:00

Apo-Warfarin · DIN 02242929 · 10mg · tablet

General benefitMarketed · checked 2026-09-02
StatusGeneral benefit
Write on scriptno code needed
Patient paysPatient pays: program not supplied; amount cannot be determined.
Private plan unknown: ask. If yes, check its coverage and payer coordination; if no, see the public routes below.
1 brand, same coverage
Apo-Warfarin · DIN 02242929 Manufacturer: Apotex Inc.; listing date 2001-06-07 Health Canada: Marketed since 2000-10-16 · brand APO-WARFARIN · ATC B01AA03 WARFARIN · form Tablet · route Oral · ingredients WARFARIN SODIUM 10 MG · company Apotex inc · schedule Prescription
Check this DIN again · Health Canada product record

Apo-Warfarin: Formulary list price $0.1211/unit (unit not stated in source; not the patient's cost)

Ministry pays: $0.1211 per source unit.

Source explanation: The formulary price is what ODB pays; the cash price at the counter is set by the pharmacy.

Formulary data: Ontario extract of Aug 26, 2026 · Health Canada DPD extract of Sep 2, 2026 (Open Government Licence – Canada) · https://health-products.canada.ca/dpd-bdpp/info?lang=eng&code=66767 · Verify on the e-Formulary ↗ (DIN 02242929)

Source record
DIN 02242929: Apo-Warfarin Raw flags: sec3=Y Item: 201200008; group id 263; item number 0530; lccId None; manufacturer id APX Source form: Tab; strength: 10mg Recorded listing: General benefit Source prices (unrounded): $0.1211; ministry $0.1211 Source: ODB odb-formulary-ed43-extract-2026-08-26.xml extract_date=2026-08-26 DIN=02242929 Health Canada DPD extract of Sep 2, 2026 (Open Government Licence – Canada) · https://health-products.canada.ca/dpd-bdpp/info?lang=eng&code=66767
Interchangeable products
Coumadin · DIN 01918362 · not recorded Taro-Warfarin · DIN 02242687 · $0.1211
Shortage status: resolved shortage (ended 2020-06-19); reports as of 2026-09-13T08:10:21.292534+00:00 (Health Product Shortages Canada) Source: https://healthproductshortages.ca/search?term=02242929
Shortage record checked 2026-09-13T08:10:21.292534+00:00

Taro-Warfarin · DIN 02242687 · 10mg · tablet

General benefitMarketed · checked 2026-09-02
StatusGeneral benefit
Write on scriptno code needed
Patient paysPatient pays: program not supplied; amount cannot be determined.
Private plan unknown: ask. If yes, check its coverage and payer coordination; if no, see the public routes below.
1 brand, same coverage
Taro-Warfarin · DIN 02242687 Manufacturer: Taro Pharmaceuticals Inc.; listing date 2001-06-07 Health Canada: Marketed since 2000-08-09 · brand TARO-WARFARIN · ATC B01AA03 WARFARIN · form Tablet · route Oral · ingredients WARFARIN SODIUM 10 MG · company Taro pharmaceuticals inc · schedule Prescription
Check this DIN again · Health Canada product record

Taro-Warfarin: Formulary list price $0.1211/unit (unit not stated in source; not the patient's cost)

Ministry pays: $0.1211 per source unit.

Source explanation: The formulary price is what ODB pays; the cash price at the counter is set by the pharmacy.

Formulary data: Ontario extract of Aug 26, 2026 · Health Canada DPD extract of Sep 2, 2026 (Open Government Licence – Canada) · https://health-products.canada.ca/dpd-bdpp/info?lang=eng&code=66477 · Verify on the e-Formulary ↗ (DIN 02242687)

Source record
DIN 02242687: Taro-Warfarin Raw flags: sec3=Y Item: 201200008; group id 263; item number 0530; lccId None; manufacturer id TAR Source form: Tab; strength: 10mg Recorded listing: General benefit Source prices (unrounded): $0.1211; ministry $0.1211 Source: ODB odb-formulary-ed43-extract-2026-08-26.xml extract_date=2026-08-26 DIN=02242687 Health Canada DPD extract of Sep 2, 2026 (Open Government Licence – Canada) · https://health-products.canada.ca/dpd-bdpp/info?lang=eng&code=66477
Interchangeable products
Apo-Warfarin · DIN 02242929 · $0.1211 Coumadin · DIN 01918362 · not recorded
Shortage status: resolved shortage (ended 2026-03-06); reports as of 2026-09-13T08:10:21.292534+00:00 (Health Product Shortages Canada) Source: https://healthproductshortages.ca/search?term=02242687
Shortage record checked 2026-09-13T08:10:21.292534+00:00

Taro-Warfarin · DIN 02242686 · 6mg · tablet

Off-Formulary Interchangeable, not an ODB benefitMarketed · checked 2026-09-02
StatusOff-Formulary Interchangeable, not an ODB benefit
Write on scriptnot a benefit; no Exceptional Access criteria on record; see alternatives
Patient paysPatient pays: program not supplied; amount cannot be determined.
Private plan unknown: ask. If yes, check its coverage and payer coordination; if no, see the public routes below.
1 brand, same coverage
Taro-Warfarin · DIN 02242686 Manufacturer: Taro Pharmaceuticals Inc.; listing date 2008-12-03 Health Canada: Marketed since 2000-08-09 · brand TARO-WARFARIN · ATC B01AA03 WARFARIN · form Tablet · route Oral · ingredients WARFARIN SODIUM 6 MG · company Taro pharmaceuticals inc · schedule Prescription
Check this DIN again · Health Canada product record

Formulary data: Ontario extract of Aug 26, 2026 · Health Canada DPD extract of Sep 2, 2026 (Open Government Licence – Canada) · https://health-products.canada.ca/dpd-bdpp/info?lang=eng&code=66476 · Verify on the e-Formulary ↗ (DIN 02242686)

Source record
DIN 02242686: Taro-Warfarin Raw flags: notABenefit=Y, sec3=Y, sec3b=Y Item: 201200077; group id 263; item number 0529; lccId None; manufacturer id TAR Source form: Tab; strength: 6mg Recorded listing: Off-Formulary Interchangeable, not an ODB benefit Source prices (unrounded): $0.5160; ministry not recorded Source: ODB odb-formulary-ed43-extract-2026-08-26.xml extract_date=2026-08-26 DIN=02242686 Health Canada DPD extract of Sep 2, 2026 (Open Government Licence – Canada) · https://health-products.canada.ca/dpd-bdpp/info?lang=eng&code=66476
Interchangeable products
Coumadin · DIN 02240206 · not recorded
Shortage status: resolved shortage (ended 2024-03-30); reports as of 2026-09-13T08:10:21.292534+00:00 (Health Product Shortages Canada) Source: https://healthproductshortages.ca/search?term=02242686
Shortage record checked 2026-09-13T08:10:21.292534+00:00

Coumadin · DIN 01918311 · 1mg · tablet

Listed, not a benefit; Health Canada lists this DIN as Cancelled post market since 2020-06-30 — choose a marketed DIN from the same-category list.Discontinued 2020-06-30 · checked 2026-09-02
StatusListed, not a benefit; Health Canada lists this DIN as Cancelled post market since 2020-06-30 — choose a marketed DIN from the same-category list.
Write on scriptnot a benefit; no Exceptional Access criteria on record; see alternatives; Health Canada lists this DIN as Cancelled post market since 2020-06-30 — choose a marketed DIN from the same-category list.
Patient paysPatient pays: program not supplied; amount cannot be determined.
Private plan unknown: ask. If yes, check its coverage and payer coordination; if no, see the public routes below.
1 brand, same coverage
Coumadin · DIN 01918311 Manufacturer: Bristol Myers Squibb Canada Inc; listing date 1996-10-01 Health Canada: Cancelled post market since 2020-06-30 · brand COUMADIN TAB 1MG · ATC B01AA03 WARFARIN · form Tablet · route Oral · ingredients WARFARIN SODIUM 1 MG · company Bristol-myers squibb canada · schedule Prescription
Check this DIN again · Health Canada product record

Coumadin: Formulary list price not recorded/unit (unit not stated in source; not the patient's cost)

Formulary data: Ontario extract of Aug 26, 2026 · Health Canada DPD extract of Sep 2, 2026 (Open Government Licence – Canada) · https://health-products.canada.ca/dpd-bdpp/info?lang=eng&code=12818 · Verify on the e-Formulary ↗ (DIN 01918311)

Source record
DIN 01918311: Coumadin Raw flags: notABenefit=Y, sec3=Y Item: 201200026; group id 263; item number 0523; lccId None; manufacturer id BQU Source form: Tab; strength: 1mg Recorded listing: Listed, not a benefit; ODB pays only for the benefit products in this interchangeable category Source prices (unrounded): not recorded; ministry not recorded Source: ODB odb-formulary-ed43-extract-2026-08-26.xml extract_date=2026-08-26 DIN=01918311 Health Canada DPD extract of Sep 2, 2026 (Open Government Licence – Canada) · https://health-products.canada.ca/dpd-bdpp/info?lang=eng&code=12818
Interchangeable products
Apo-Warfarin · DIN 02242924 · $0.0796 Taro-Warfarin · DIN 02242680 · $0.0796
Shortage status: discontinued (2020-08-31, reported by BRISTOL-MYERS SQUIBB CANADA); reports as of 2026-09-13T08:10:21.292534+00:00 (Health Product Shortages Canada) Source: https://healthproductshortages.ca/search?term=01918311
Shortage record checked 2026-09-13T08:10:21.292534+00:00
Health Canada lists this DIN as Cancelled post market since 2020-06-30 — choose a marketed DIN from the same-category list.

Coumadin · DIN 01918338 · 2mg · tablet

Listed, not a benefit; Health Canada lists this DIN as Cancelled post market since 2020-06-21 — choose a marketed DIN from the same-category list.Discontinued 2020-06-21 · checked 2026-09-02
StatusListed, not a benefit; Health Canada lists this DIN as Cancelled post market since 2020-06-21 — choose a marketed DIN from the same-category list.
Write on scriptnot a benefit; no Exceptional Access criteria on record; see alternatives; Health Canada lists this DIN as Cancelled post market since 2020-06-21 — choose a marketed DIN from the same-category list.
Patient paysPatient pays: program not supplied; amount cannot be determined.
Private plan unknown: ask. If yes, check its coverage and payer coordination; if no, see the public routes below.
1 brand, same coverage
Coumadin · DIN 01918338 Manufacturer: Bristol Myers Squibb Canada Inc; listing date 1996-10-01 Health Canada: Cancelled post market since 2020-06-21 · brand COUMADIN TAB 2MG · ATC B01AA03 WARFARIN · form Tablet · route Oral · ingredients WARFARIN SODIUM 2 MG · company Bristol-myers squibb canada · schedule Prescription
Check this DIN again · Health Canada product record

Coumadin: Formulary list price not recorded/unit (unit not stated in source; not the patient's cost)

Formulary data: Ontario extract of Aug 26, 2026 · Health Canada DPD extract of Sep 2, 2026 (Open Government Licence – Canada) · https://health-products.canada.ca/dpd-bdpp/info?lang=eng&code=13536 · Verify on the e-Formulary ↗ (DIN 01918338)

Source record
DIN 01918338: Coumadin Raw flags: notABenefit=Y, sec3=Y Item: 201200027; group id 263; item number 0524; lccId None; manufacturer id BQU Source form: Tab; strength: 2mg Recorded listing: Listed, not a benefit; ODB pays only for the benefit products in this interchangeable category Source prices (unrounded): not recorded; ministry not recorded Source: ODB odb-formulary-ed43-extract-2026-08-26.xml extract_date=2026-08-26 DIN=01918338 Health Canada DPD extract of Sep 2, 2026 (Open Government Licence – Canada) · https://health-products.canada.ca/dpd-bdpp/info?lang=eng&code=13536
Interchangeable products
Apo-Warfarin · DIN 02242925 · $0.0841 Taro-Warfarin · DIN 02242681 · $0.0841
Shortage status: discontinued (2020-08-31, reported by BRISTOL-MYERS SQUIBB CANADA); reports as of 2026-09-13T08:10:21.292534+00:00 (Health Product Shortages Canada) Source: https://healthproductshortages.ca/search?term=01918338
Shortage record checked 2026-09-13T08:10:21.292534+00:00
Health Canada lists this DIN as Cancelled post market since 2020-06-21 — choose a marketed DIN from the same-category list.

Coumadin · DIN 01918346 · 2.5mg · tablet

Listed, not a benefit; Health Canada lists this DIN as Cancelled post market since 2020-08-24 — choose a marketed DIN from the same-category list.Discontinued 2020-08-24 · checked 2026-09-02
StatusListed, not a benefit; Health Canada lists this DIN as Cancelled post market since 2020-08-24 — choose a marketed DIN from the same-category list.
Write on scriptnot a benefit; no Exceptional Access criteria on record; see alternatives; Health Canada lists this DIN as Cancelled post market since 2020-08-24 — choose a marketed DIN from the same-category list.
Patient paysPatient pays: program not supplied; amount cannot be determined.
Private plan unknown: ask. If yes, check its coverage and payer coordination; if no, see the public routes below.
1 brand, same coverage
Coumadin · DIN 01918346 Manufacturer: Bristol Myers Squibb Canada Inc; listing date 1996-10-01 Health Canada: Cancelled post market since 2020-08-24 · brand COUMADIN TAB 2.5MG · ATC B01AA03 WARFARIN · form Tablet · route Oral · ingredients WARFARIN SODIUM 2.5 MG · company Bristol-myers squibb canada · schedule Prescription
Check this DIN again · Health Canada product record

Coumadin: Formulary list price not recorded/unit (unit not stated in source; not the patient's cost)

Formulary data: Ontario extract of Aug 26, 2026 · Health Canada DPD extract of Sep 2, 2026 (Open Government Licence – Canada) · https://health-products.canada.ca/dpd-bdpp/info?lang=eng&code=13419 · Verify on the e-Formulary ↗ (DIN 01918346)

Source record
DIN 01918346: Coumadin Raw flags: notABenefit=Y, sec3=Y Item: 201200010; group id 263; item number 0525; lccId None; manufacturer id BQU Source form: Tab; strength: 2.5mg Recorded listing: Listed, not a benefit; ODB pays only for the benefit products in this interchangeable category Source prices (unrounded): not recorded; ministry not recorded Source: ODB odb-formulary-ed43-extract-2026-08-26.xml extract_date=2026-08-26 DIN=01918346 Health Canada DPD extract of Sep 2, 2026 (Open Government Licence – Canada) · https://health-products.canada.ca/dpd-bdpp/info?lang=eng&code=13419
Interchangeable products
Apo-Warfarin · DIN 02242926 · $0.0674 Taro-Warfarin · DIN 02242682 · $0.0674
Shortage status: discontinued (2020-08-31, reported by BRISTOL-MYERS SQUIBB CANADA); reports as of 2026-09-13T08:10:21.292534+00:00 (Health Product Shortages Canada) Source: https://healthproductshortages.ca/search?term=01918346
Shortage record checked 2026-09-13T08:10:21.292534+00:00
Health Canada lists this DIN as Cancelled post market since 2020-08-24 — choose a marketed DIN from the same-category list.

Coumadin · DIN 02240205 · 3mg · tablet

Listed, not a benefit; Health Canada lists this DIN as Cancelled post market since 2020-08-24 — choose a marketed DIN from the same-category list.Discontinued 2020-08-24 · checked 2026-09-02
StatusListed, not a benefit; Health Canada lists this DIN as Cancelled post market since 2020-08-24 — choose a marketed DIN from the same-category list.
Write on scriptnot a benefit; no Exceptional Access criteria on record; see alternatives; Health Canada lists this DIN as Cancelled post market since 2020-08-24 — choose a marketed DIN from the same-category list.
Patient paysPatient pays: program not supplied; amount cannot be determined.
Private plan unknown: ask. If yes, check its coverage and payer coordination; if no, see the public routes below.
1 brand, same coverage
Coumadin · DIN 02240205 Manufacturer: Bristol Myers Squibb Canada Inc; listing date 2001-06-07 Health Canada: Cancelled post market since 2020-08-24 · brand COUMADIN TAB 3MG · ATC B01AA03 WARFARIN · form Tablet · route Oral · ingredients WARFARIN SODIUM 3 MG · company Bristol-myers squibb canada · schedule Prescription
Check this DIN again · Health Canada product record

Coumadin: Formulary list price not recorded/unit (unit not stated in source; not the patient's cost)

Formulary data: Ontario extract of Aug 26, 2026 · Health Canada DPD extract of Sep 2, 2026 (Open Government Licence – Canada) · https://health-products.canada.ca/dpd-bdpp/info?lang=eng&code=63731 · Verify on the e-Formulary ↗ (DIN 02240205)

Source record
DIN 02240205: Coumadin Raw flags: notABenefit=Y, sec3=Y Item: 201200062; group id 263; item number 0526; lccId None; manufacturer id BQU Source form: Tab; strength: 3mg Recorded listing: Listed, not a benefit; ODB pays only for the benefit products in this interchangeable category Source prices (unrounded): not recorded; ministry not recorded Source: ODB odb-formulary-ed43-extract-2026-08-26.xml extract_date=2026-08-26 DIN=02240205 Health Canada DPD extract of Sep 2, 2026 (Open Government Licence – Canada) · https://health-products.canada.ca/dpd-bdpp/info?lang=eng&code=63731
Interchangeable products
Apo-Warfarin · DIN 02245618 · $0.1043 Taro-Warfarin · DIN 02242683 · $0.1043
Shortage status: discontinued (2020-08-31, reported by BRISTOL-MYERS SQUIBB CANADA); reports as of 2026-09-13T08:10:21.292534+00:00 (Health Product Shortages Canada) Source: https://healthproductshortages.ca/search?term=02240205
Shortage record checked 2026-09-13T08:10:21.292534+00:00
Health Canada lists this DIN as Cancelled post market since 2020-08-24 — choose a marketed DIN from the same-category list.

Coumadin · DIN 02007959 · 4mg · tablet

Listed, not a benefit; Health Canada lists this DIN as Cancelled post market since 2020-06-25 — choose a marketed DIN from the same-category list.Discontinued 2020-06-25 · checked 2026-09-02
StatusListed, not a benefit; Health Canada lists this DIN as Cancelled post market since 2020-06-25 — choose a marketed DIN from the same-category list.
Write on scriptnot a benefit; no Exceptional Access criteria on record; see alternatives; Health Canada lists this DIN as Cancelled post market since 2020-06-25 — choose a marketed DIN from the same-category list.
Patient paysPatient pays: program not supplied; amount cannot be determined.
Private plan unknown: ask. If yes, check its coverage and payer coordination; if no, see the public routes below.
1 brand, same coverage
Coumadin · DIN 02007959 Manufacturer: Bristol Myers Squibb Canada Inc; listing date 1996-10-01 Health Canada: Cancelled post market since 2020-06-25 · brand COUMADIN TAB 4MG · ATC B01AA03 WARFARIN · form Tablet · route Oral · ingredients WARFARIN SODIUM 4 MG · company Bristol-myers squibb canada · schedule Prescription
Check this DIN again · Health Canada product record

Coumadin: Formulary list price not recorded/unit (unit not stated in source; not the patient's cost)

Formulary data: Ontario extract of Aug 26, 2026 · Health Canada DPD extract of Sep 2, 2026 (Open Government Licence – Canada) · https://health-products.canada.ca/dpd-bdpp/info?lang=eng&code=13375 · Verify on the e-Formulary ↗ (DIN 02007959)

Source record
DIN 02007959: Coumadin Raw flags: notABenefit=Y, sec3=Y Item: 201200028; group id 263; item number 0527; lccId None; manufacturer id BQU Source form: Tab; strength: 4mg Recorded listing: Listed, not a benefit; ODB pays only for the benefit products in this interchangeable category Source prices (unrounded): not recorded; ministry not recorded Source: ODB odb-formulary-ed43-extract-2026-08-26.xml extract_date=2026-08-26 DIN=02007959 Health Canada DPD extract of Sep 2, 2026 (Open Government Licence – Canada) · https://health-products.canada.ca/dpd-bdpp/info?lang=eng&code=13375
Interchangeable products
Apo-Warfarin · DIN 02242927 · $0.1043 Taro-Warfarin · DIN 02242684 · $0.1043
Shortage status: discontinued (2020-06-15, reported by BRISTOL-MYERS SQUIBB CANADA); reports as of 2026-09-13T08:10:21.292534+00:00 (Health Product Shortages Canada) Source: https://healthproductshortages.ca/search?term=02007959
Shortage record checked 2026-09-13T08:10:21.292534+00:00
Health Canada lists this DIN as Cancelled post market since 2020-06-25 — choose a marketed DIN from the same-category list.

Coumadin · DIN 01918354 · 5mg · tablet

Listed, not a benefit; Health Canada lists this DIN as Cancelled post market since 2020-08-20 — choose a marketed DIN from the same-category list.Discontinued 2020-08-20 · checked 2026-09-02
StatusListed, not a benefit; Health Canada lists this DIN as Cancelled post market since 2020-08-20 — choose a marketed DIN from the same-category list.
Write on scriptnot a benefit; no Exceptional Access criteria on record; see alternatives; Health Canada lists this DIN as Cancelled post market since 2020-08-20 — choose a marketed DIN from the same-category list.
Patient paysPatient pays: program not supplied; amount cannot be determined.
Private plan unknown: ask. If yes, check its coverage and payer coordination; if no, see the public routes below.
1 brand, same coverage
Coumadin · DIN 01918354 Manufacturer: Bristol Myers Squibb Canada Inc; listing date 1996-10-01 Health Canada: Cancelled post market since 2020-08-20 · brand COUMADIN TAB 5MG · ATC B01AA03 WARFARIN · form Tablet · route Oral · ingredients WARFARIN SODIUM 5 MG · company Bristol-myers squibb canada · schedule Prescription
Check this DIN again · Health Canada product record

Coumadin: Formulary list price not recorded/unit (unit not stated in source; not the patient's cost)

Formulary data: Ontario extract of Aug 26, 2026 · Health Canada DPD extract of Sep 2, 2026 (Open Government Licence – Canada) · https://health-products.canada.ca/dpd-bdpp/info?lang=eng&code=12819 · Verify on the e-Formulary ↗ (DIN 01918354)

Source record
DIN 01918354: Coumadin Raw flags: notABenefit=Y, sec3=Y Item: 201200035; group id 263; item number 0528; lccId None; manufacturer id BQU Source form: Tab; strength: 5mg Recorded listing: Listed, not a benefit; ODB pays only for the benefit products in this interchangeable category Source prices (unrounded): not recorded; ministry not recorded Source: ODB odb-formulary-ed43-extract-2026-08-26.xml extract_date=2026-08-26 DIN=01918354 Health Canada DPD extract of Sep 2, 2026 (Open Government Licence – Canada) · https://health-products.canada.ca/dpd-bdpp/info?lang=eng&code=12819
Interchangeable products
Apo-Warfarin · DIN 02242928 · $0.0675 Taro-Warfarin · DIN 02242685 · $0.0675
Shortage status: discontinued (2020-08-10, reported by BRISTOL-MYERS SQUIBB CANADA); reports as of 2026-09-13T08:10:21.292534+00:00 (Health Product Shortages Canada) Source: https://healthproductshortages.ca/search?term=01918354
Shortage record checked 2026-09-13T08:10:21.292534+00:00
Health Canada lists this DIN as Cancelled post market since 2020-08-20 — choose a marketed DIN from the same-category list.

Coumadin · DIN 02240206 · 6mg · tablet

Listed, not a benefit; Health Canada lists this DIN as Cancelled post market since 2020-06-25 — choose a marketed DIN from the same-category list.Discontinued 2020-06-25 · checked 2026-09-02
StatusListed, not a benefit; Health Canada lists this DIN as Cancelled post market since 2020-06-25 — choose a marketed DIN from the same-category list.
Write on scriptnot a benefit; no Exceptional Access criteria on record; see alternatives; Health Canada lists this DIN as Cancelled post market since 2020-06-25 — choose a marketed DIN from the same-category list.
Patient paysPatient pays: program not supplied; amount cannot be determined.
Private plan unknown: ask. If yes, check its coverage and payer coordination; if no, see the public routes below.
1 brand, same coverage
Coumadin · DIN 02240206 Manufacturer: Bristol Myers Squibb Canada Inc; listing date 2008-06-27 Health Canada: Cancelled post market since 2020-06-25 · brand COUMADIN TAB 6 MG · ATC B01AA03 WARFARIN · form Tablet · route Oral · ingredients WARFARIN SODIUM 6 MG · company Bristol-myers squibb canada · schedule Prescription
Check this DIN again · Health Canada product record

Coumadin: Formulary list price not recorded/unit (unit not stated in source; not the patient's cost)

Formulary data: Ontario extract of Aug 26, 2026 · Health Canada DPD extract of Sep 2, 2026 (Open Government Licence – Canada) · https://health-products.canada.ca/dpd-bdpp/info?lang=eng&code=63732 · Verify on the e-Formulary ↗ (DIN 02240206)

Source record
DIN 02240206: Coumadin Raw flags: notABenefit=Y, sec3=Y Item: 201200077; group id 263; item number 0529; lccId None; manufacturer id BQU Source form: Tab; strength: 6mg Recorded listing: Listed, not a benefit; ODB pays only for the benefit products in this interchangeable category Source prices (unrounded): not recorded; ministry not recorded Source: ODB odb-formulary-ed43-extract-2026-08-26.xml extract_date=2026-08-26 DIN=02240206 Health Canada DPD extract of Sep 2, 2026 (Open Government Licence – Canada) · https://health-products.canada.ca/dpd-bdpp/info?lang=eng&code=63732
Interchangeable products
Taro-Warfarin · DIN 02242686 · not recorded
Shortage status: discontinued (2020-07-10, reported by BRISTOL-MYERS SQUIBB CANADA); reports as of 2026-09-13T08:10:21.292534+00:00 (Health Product Shortages Canada) Source: https://healthproductshortages.ca/search?term=02240206
Shortage record checked 2026-09-13T08:10:21.292534+00:00
Health Canada lists this DIN as Cancelled post market since 2020-06-25 — choose a marketed DIN from the same-category list.

Coumadin · DIN 01918362 · 10mg · tablet

Listed, not a benefit; Health Canada lists this DIN as Cancelled post market since 2020-06-22 — choose a marketed DIN from the same-category list.Discontinued 2020-06-22 · checked 2026-09-02
StatusListed, not a benefit; Health Canada lists this DIN as Cancelled post market since 2020-06-22 — choose a marketed DIN from the same-category list.
Write on scriptnot a benefit; no Exceptional Access criteria on record; see alternatives; Health Canada lists this DIN as Cancelled post market since 2020-06-22 — choose a marketed DIN from the same-category list.
Patient paysPatient pays: program not supplied; amount cannot be determined.
Private plan unknown: ask. If yes, check its coverage and payer coordination; if no, see the public routes below.
1 brand, same coverage
Coumadin · DIN 01918362 Manufacturer: Bristol Myers Squibb Canada Inc; listing date 1996-10-01 Health Canada: Cancelled post market since 2020-06-22 · brand COUMADIN TAB 10MG · ATC B01AA03 WARFARIN · form Tablet · route Oral · ingredients WARFARIN SODIUM 10 MG · company Bristol-myers squibb canada · schedule Prescription
Check this DIN again · Health Canada product record

Coumadin: Formulary list price not recorded/unit (unit not stated in source; not the patient's cost)

Formulary data: Ontario extract of Aug 26, 2026 · Health Canada DPD extract of Sep 2, 2026 (Open Government Licence – Canada) · https://health-products.canada.ca/dpd-bdpp/info?lang=eng&code=13418 · Verify on the e-Formulary ↗ (DIN 01918362)

Source record
DIN 01918362: Coumadin Raw flags: notABenefit=Y, sec3=Y Item: 201200008; group id 263; item number 0530; lccId None; manufacturer id BQU Source form: Tab; strength: 10mg Recorded listing: Listed, not a benefit; ODB pays only for the benefit products in this interchangeable category Source prices (unrounded): not recorded; ministry not recorded Source: ODB odb-formulary-ed43-extract-2026-08-26.xml extract_date=2026-08-26 DIN=01918362 Health Canada DPD extract of Sep 2, 2026 (Open Government Licence – Canada) · https://health-products.canada.ca/dpd-bdpp/info?lang=eng&code=13418
Interchangeable products
Apo-Warfarin · DIN 02242929 · $0.1211 Taro-Warfarin · DIN 02242687 · $0.1211
Shortage status: discontinued (2020-06-01, reported by BRISTOL-MYERS SQUIBB CANADA); reports as of 2026-09-13T08:10:21.292534+00:00 (Health Product Shortages Canada) Source: https://healthproductshortages.ca/search?term=01918362
Shortage record checked 2026-09-13T08:10:21.292534+00:00
Health Canada lists this DIN as Cancelled post market since 2020-06-22 — choose a marketed DIN from the same-category list.
Other drugs in the same formulary class (20:12 Coagulants and Anti-Coagulants) and how they are covered

Matched class: 20:12 Coagulants and Anti-Coagulants

Drug-class inventory only. Lists recorded Ontario formulary products, not every Canadian medication; does not recommend treatment. Covered without a code on the Ontario formulary: APIXABAN, ENOXAPARIN, RIVAROXABAN Some products covered without a code (check the product listing): DABIGATRAN ETEXILATE, EDOXABAN 20:12 Coagulants and Anti-Coagulants

APIXABAN

· 38 products · General benefit · strengths: 2.5mg, 5mg · Tab

DABIGATRAN ETEXILATE

· 6 products · Off-Formulary Interchangeable, not an ODB benefit (2), General benefit (4) · strengths: 75mg, 110mg, 150mg · Cap

ENOXAPARIN

· 37 products · General benefit · strengths: 20mg/0.2mL, 30mg/0.3mL, 40mg/0.4mL, 60mg/0.6mL, 80mg/0.8mL, 120mg/0.8mL, 100mg/mL, 150mg/mL, 300mg/3mL · Inj Sol-0.2mL Pref Syr (Preservative-Free), Inj Sol-0.3mL Pref Syr (Preservative-Free), Inj Sol-0.4mL Pref Syr (Preservative-Free), Inj Sol-0.6mL Pref Syr (Preservative-Free), Inj Sol-0.8mL Pref Syr (Preservative-Free), Inj Sol-1mL Pref Syr (Preservative-Free), Inj Sol-3mL Vial Pk (With Preservative)

RIVAROXABAN

· 48 products · General benefit · strengths: 2.5mg, 10mg, 15mg, 20mg · Tab

DALTEPARIN SODIUM

· 10 products · Limited Use, codes 186, 187, 188, 189 · strengths: 3500IU/0.28mL, 7500IU/0.3mL, 2500IU/0.2mL, 5000IU/0.2mL, 10000IU/0.4mL, 12500IU/0.5mL, 15000IU/0.6mL, 18000IU/0.72mL, 16500IU/0.66mL, 25000IU/mL · Inj Pref Syr, Inj Pref Syr-0.66mL Pk, Multidose 3.8mL Pk

FONDAPARINUX SODIUM

· 4 products · Limited Use, codes 378 (2), Off-Formulary Interchangeable, not an ODB benefit (2) · strengths: 2.5mg/0.5mL, 7.5mg/0.6mL · Inj Sol-Pref Syr 0.5mL Pk (Preservative Free), Inj Sol-Pref Syr 0.6mL Pk (Preservative Free)

NADROPARIN CALCIUM

· 7 products · Limited Use, codes 186, 187, 188, 189 · strengths: 9500IU/mL, 19000IU/mL · Pref Syr-0.3mL Pk, Pref Syr-0.4mL Pk, Pref Syr-0.6mL Pk, Pref Syr-0.8mL Pk, Pref Syr-1.0mL Pk

TICAGRELOR

· 10 products · Off-Formulary Interchangeable, not an ODB benefit (5), Limited Use, codes 441 (5) · strengths: 60mg, 90mg · Tab

TINZAPARIN SODIUM

· 11 products · Limited Use, codes 186, 187, 188, 189, 323 · strengths: 2500IU/0.25mL, 8000IU/0.4mL, 12000IU/0.6mL, 16000IU/0.8mL, 3500IU/0.35mL, 4500IU/0.45mL, 10000IU/0.5mL, 14000IU/0.7mL, 18000IU/0.9mL, 10000IU/mL, 20000IU/mL · Inj Pref Syr, Inj-2mL Pk

EPTIFIBATIDE

· 6 products · Off-Formulary Interchangeable, not an ODB benefit · strengths: 0.75mg/mL, 2mg/mL · 100mL Vial Pk, 10mL Vial Pk Source: formulary-ed43-front-matter.txt Part V; ODB odb-formulary-ed43-extract-2026-08-26.xml extract_date=2026-08-26; class 20:12 20:12:04 Direct Factor Xa Inhibitors

EDOXABAN

· 11 products · General benefit; DIN status E (meaning unconfirmed); confirm discontinuation/availability with Health Canada (3), General benefit (8) · strengths: 15mg, 30mg, 60mg · Tab Source: formulary-ed43-front-matter.txt Part V; ODB odb-formulary-ed43-extract-2026-08-26.xml extract_date=2026-08-26; class 20:12:04 20:12:16 Hemostatics

TRANEXAMIC ACID

· 5 products · Off-Formulary Interchangeable, not an ODB benefit · strengths: 500mg · Tab Source: formulary-ed43-front-matter.txt Part V; ODB odb-formulary-ed43-extract-2026-08-26.xml extract_date=2026-08-26; class 20:12:16
Full class listing Related classes: 20:04 Antianemia Drugs, 20:16 Hematopoietic Agents, 20:24 Hemorrheologic Agents Same formulary class, not same indication: class membership alone does not establish equivalent uses.
Other drugs whose Health Canada label lists a similar indication: prophylaxis
From Health Canada product monographs; label wording only, not a treatment recommendation. Matching is lexical and uses one held product label per generic; formulations and qualifying criteria may differ. No displayed matched alternative is a general benefit. MEFLOQUINE HCL · Off-Formulary Interchangeable, not an ODB benefit 1 INDICATIONS MEFLOQUINE (mefloquine tablets) is indicated for: • Prophylaxis: Prophylaxis of P. falciparum and P. vivax malaria infections, including prophylaxis of chloroquine-resistant strains of P. falciparum. PM: https://pdf.hres.ca/dpd_pm/00080420.PDF; date MAY 01, 2025; DIN 02244366; fetched 2026-09-10 Product monograph Coverage source: ON formulary extract 2026-08-26
What the Health Canada label says it is for
1 Indications TARO-WARFARIN (warfarin sodium) tablets are indicated for: • Prophylaxis and/or treatment of venous thrombosis and its extension, • Pulmonary embolism, • Atrial fibrillation with embolization, and • As an adjunct in the prophylaxis of systemic embolism after myocardial infarction, including stroke and reinfarction. The following are some of the more common clinical disorders which may be associated with or predispose patients to the above indications: 1. Thrombophlebitis https://pdf.hres.ca/dpd_pm/00084195.PDF PM date: 2026-04-08 Source product: TARO-WARFARIN; DIN 02242680; fetched 2026-09-10 Product monograph posted by Health Canada; excerpt for lookup only.

Availability

Apo-Warfarin · DIN 02242926 Shortage status: active shortage (reported 2024-05-28, last updated 2024-10-24); reports as of 2026-09-13T08:10:21.292534+00:00 (Health Product Shortages Canada) Source: https://healthproductshortages.ca/search?term=02242926

Check this DIN again

Taro-Warfarin · DIN 02242683 Shortage status: discontinued (2021-11-25, reported by TARO PHARMACEUTICALS INC); reports as of 2026-09-13T08:10:21.292534+00:00 (Health Product Shortages Canada) Source: https://healthproductshortages.ca/search?term=02242683

Check this DIN again

Taro-Warfarin · DIN 02242685 Shortage status: discontinued (2023-09-22, reported by TARO PHARMACEUTICALS INC); reports as of 2026-09-13T08:10:21.292534+00:00 (Health Product Shortages Canada) Source: https://healthproductshortages.ca/search?term=02242685

Check this DIN again

Coumadin · DIN 01918311 Shortage status: discontinued (2020-08-31, reported by BRISTOL-MYERS SQUIBB CANADA); reports as of 2026-09-13T08:10:21.292534+00:00 (Health Product Shortages Canada) Source: https://healthproductshortages.ca/search?term=01918311

Check this DIN again

Coumadin · DIN 01918338 Shortage status: discontinued (2020-08-31, reported by BRISTOL-MYERS SQUIBB CANADA); reports as of 2026-09-13T08:10:21.292534+00:00 (Health Product Shortages Canada) Source: https://healthproductshortages.ca/search?term=01918338

Check this DIN again

Coumadin · DIN 01918346 Shortage status: discontinued (2020-08-31, reported by BRISTOL-MYERS SQUIBB CANADA); reports as of 2026-09-13T08:10:21.292534+00:00 (Health Product Shortages Canada) Source: https://healthproductshortages.ca/search?term=01918346

Check this DIN again

Coumadin · DIN 02240205 Shortage status: discontinued (2020-08-31, reported by BRISTOL-MYERS SQUIBB CANADA); reports as of 2026-09-13T08:10:21.292534+00:00 (Health Product Shortages Canada) Source: https://healthproductshortages.ca/search?term=02240205

Check this DIN again

Coumadin · DIN 02007959 Shortage status: discontinued (2020-06-15, reported by BRISTOL-MYERS SQUIBB CANADA); reports as of 2026-09-13T08:10:21.292534+00:00 (Health Product Shortages Canada) Source: https://healthproductshortages.ca/search?term=02007959

Check this DIN again

Coumadin · DIN 01918354 Shortage status: discontinued (2020-08-10, reported by BRISTOL-MYERS SQUIBB CANADA); reports as of 2026-09-13T08:10:21.292534+00:00 (Health Product Shortages Canada) Source: https://healthproductshortages.ca/search?term=01918354

Check this DIN again

Coumadin · DIN 02240206 Shortage status: discontinued (2020-07-10, reported by BRISTOL-MYERS SQUIBB CANADA); reports as of 2026-09-13T08:10:21.292534+00:00 (Health Product Shortages Canada) Source: https://healthproductshortages.ca/search?term=02240206

Check this DIN again

Coumadin · DIN 01918362 Shortage status: discontinued (2020-06-01, reported by BRISTOL-MYERS SQUIBB CANADA); reports as of 2026-09-13T08:10:21.292534+00:00 (Health Product Shortages Canada) Source: https://healthproductshortages.ca/search?term=01918362

Check this DIN again

Other review policies

For Taro-Warfarin, Coumadin: no applicable EAP criteria are held and no ODB benefit is established. These policies do not establish coverage.

For rare, immediately life-, limb- or organ-threatening circumstances, the Compassionate Review Policy may consider an unfunded drug or indication, subject to its criteria and without bypassing the drug review process. Compassionate Review Policy

Compassionate Review Policy: source quote
Where there are rare clinical circumstances in immediately life, limb, or organ-threatening conditions, the Executive Officer will also consider requests for drugs or indications in situations where there has not been a decision by the Executive Officer to provide funding of the drug or indication as part of the Ontario Drug Benefit program (and the EAP), and the drug or indication requested would not circumvent the established review process for new drugs or indications as part of the drug submission process for listing within the Ontario Drug Benefit program. Requests must meet the criteria for the Compassionate Review Policy.

Ontario source; updated September 15, 2026

For cancer drugs, Case-by-Case Review considers rare, immediately life-threatening circumstances when no satisfactory funded treatment exists; its criteria and application process apply. Case-by-Case Review (cancer drugs)

Case-by-Case Review (cancer drugs): source quote
Note: Requests for cancer drugs are considered under the Case-by-Case Review Program (CBCRP) which is administered by Ontario Health (Cancer Care Ontario) on behalf of the Ministry of Health. The CBCRP considers funding requests for drugs (both oral therapies and injectable drugs) for the treatment of cancer in patients who have a rare clinical circumstance that is immediately life-threatening (death is likely within a matter of months) and who require treatment with an unfunded drug, because there is no other satisfactory and funded treatment. Please refer to the Ontario Health website for information on the application process, FAQs, eligibility criteria and program policies.

Ontario source; updated September 15, 2026